Today’s top gainers include the company Biogen Inc. (NASDAQ:BIIB) which is in the industry Biotechnology, gaining 6.54% today. In the last week its performance is 4.47%, and -1.31% for the past quarter. Currently, Biogen Inc., BIIB has a target price of 332.47, so today’s gain of 6.54% is a significant step towards its target price. The GAP today is therefore 6.61%.
Biogen Inc. (NASDAQ:BIIB), has a market cap of 57441.55, and is based in USA. Insider ownership is at 0.10%, and institutional ownership is 88.60%.
At the current price of 279.58, it has a dividend yield of *TBA, and its target price is 332.47. This is with a profit margin of 33.80%, and total debt/equity of 0.63. Biogen Inc. (NASDAQ:BIIB) has a P/E of 16.12, as well as a forward P/E of 13.08.
With a current EPS of 16.28, and a forecasted EPS growth for next year at 6.03%,Biogen Inc. (NASDAQ:BIIB) has had a EPS growth for the past five years at 31.30%. For the next five years EPS growth is projected to be 7.82%.
Performance for the year is -35.92%. Since its IPO date on 9/17/1991, the total performance to date is -14.34%.
Volume today for Biogen Inc. (NASDAQ:BIIB), is 4270865, while its average volume is 1807.82. Whilst the total gain today was 6.54%, it did have a day high of -4.48%.
Volatility for this week has been at 2.01%, and 2.15% for the month. The 52-week low for Biogen Inc., BIIB has been 25.36%, while the 52-week-high has reached -32.18%.
Looking at its return of investments, which is 23.50%, and its return on assets is 19.00%. Biogen Inc. (NASDAQ:BIIB) has an operating margin of 47.10%. With a sales growth of 6.70% quarter over quarter. Bearing in mind that Biogen Inc., BIIB is in the sector Healthcare, its long-term debt/equity is 0.63, and has a current ratio of 2.6 and 2.2 for quick ratio.
So what is the value of Biogen Inc.? Well its PEG is 2.06, and the P/S is 5.25, along with a P/B of 5.56. Meanwhile it has a p/cash of 16.02.